Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SKB410
i
Other names:
SKB410, MK-3120, SKB-410, SKB 410, MK 3120, MK3120
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Merck (MSD), Sichuan Kelun Pharma
Drug class:
Nectin-4-targeted antibody-drug conjugate
Related drugs:
‹
enfortumab vedotin-ejfv (14)
9MW2821 (1)
SBT6290 (1)
SHR-A2102 (1)
BAT8007 (0)
Nectin-4 ADC (0)
enfortumab vedotin-ejfv (14)
9MW2821 (1)
SBT6290 (1)
SHR-A2102 (1)
BAT8007 (0)
Nectin-4 ADC (0)
›
Associations
News
Trials
Filter by
Latest
6ms
SKB410 for Injection in Solid Tumors (clinicaltrials.gov)
P1, N=276, Recruiting, Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. | Not yet recruiting --> Recruiting
6 months ago
Enrollment open • Metastases
|
SKB410
over1year
SKB410 for Injection in Solid Tumors (clinicaltrials.gov)
P1, N=276, Not yet recruiting, Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
over 1 year ago
New P1 trial • Metastases
|
SKB410
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login